drugset / Trial / NCT05581758

A Study to Assess the Effect of Food on the Pharmacokinetics (PK) of AMG 510 in Healthy Participants

NCT05581758

Phase 1 Completed 14 enrolled Amgen
RandomizedCrossoverOpen-labelBasic science

Summary

The primary objective of the study is to evaluate the PK of AMG 510 administered in the fasted and fed state in healthy participants.

Timeline

Start
2019-11-14
Primary completion
2019-11-25
Completion
2019-12-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Sotorasib Small molecule Oral

Indications

No indication recorded.